VVUS
Transfer...
 Symbol:



NASDAQ / Sector: Healthcare / Sub-Sector: Biotechnology / Stock Type: Distressed
# of Employee: 82 / Fiscal Year End: 2016-12-31 / Stock Type: Small Core
USD / Exchange Rate: 1 at 2016-11-22 / Estimation: $Confidential / / $

VIVUS Incis a biopharmaceutical company engaged in the development and commercialization of therapeutic products for large underserved markets. Its product line includes Qsymia for sleep apnea, STENDRA for erectile dysfunction.

Competitors | AnnualReport

Competitors List | Key Matrix Details

AMGN | GILD | CELG | NVO | BIIB | SHPG | REGN | ALXN | VRTX | INCY | BMRN |

Finance Highlights

Key Ratio Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##FinanceKeyRatioHighlights}

Key Ratio Trend

{##FinanceKeyRatioTrend}

Income Statement Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2014-03-25Quarter36,691k9,533k0.0-15,550k-15,550k103,289,k74.00%-42.40%-42.40%
2014-06-25Quarter21,881k7,015k0.0-25,825k-25,825k103,350,k67.90%-118.00%-118.00%
2014-09-25Quarter33,877k7,268k0.0-15,825k-15,825k103,477,k78.50%-46.70%-46.70%
2014-12-25Quarter21,732k9,571k0.0-25,447k-25,447k103,705,k56.00%-117.10%-117.10%
2015-03-25Quarter32,166k9,896k0.0-15,466k-15,466k103,797,k69.20%-48.10%-48.10%
2015-06-25Quarter22,985k9,870k0.0-49,352k-49,352k103,845,k57.10%-214.70%-214.70%
2015-09-25Quarter24,936k11,765k0.0-16,106k-16,106k104,014,k52.80%-64.60%-64.60%
2015-12-25Quarter15,343k2,626k0.0-12,183k-12,183k103,854,k82.90%-79.40%-79.40%
2016-03-25Quarter15,324k3,704k0.0-12,708k-12,708k104,071,k75.80%-82.90%-82.90%
2016-06-25Quarter13,776k2,647k0.0-11,401k-11,401k104,126,k80.80%-82.80%-82.80%
2016-12-25Quarter81,805k2,186k0.056,563k56,563k10,719,20097.30%69.10%69.10%
2017-03-25Quarter27,012k6,167k0.0-1,056k-1,056k10,547,90077.20%-3.90%-3.90%
2017-06-25Quarter11,227k3,570k0.0-13,386k-13,386k10,571,20068.20%-119.20%-119.20%
2017-09-25Quarter15,193k3,514k0.0-5,994k-5,994k10,582,60076.90%-39.50%-39.50%
2017-12-25Quarter11,941k3,936k0.0-10,075k-10,075k10,594,20067.00%-84.40%-84.40%
2018-03-25Quarter11,900k2,721k0.0-10,653k-10,653k10,601,40077.10%-89.50%-89.50%
2018-06-25Quarter14,960k3,286k0.0-12,574k-12,574k10,611,60078.00%-84.10%-84.10%
2018-09-25Quarter18,088k3,484k9,595k-9,223k-9,223k10,628,k80.70%-51.00%-51.00%
2018-12-25Quarter20,114k5,213k6,714k-4,500k-4,500k10,633,k74.10%-22.40%-22.40%
2019-03-25Quarter16,146k4,308k0.0-7,949k-7,949k10,637,k73.30%-49.20%-49.20%
2019-06-25Quarter18,390k4,377k3,880k-5,935k-5,935k10,640,k76.20%-32.30%-32.30%

Income Statement Trend

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2015-03-25Quarter-12.33%3.81%0.00%-0.54%-0.54%0.49%-6.49%13.44%13.44%
2015-06-25Quarter5.05%40.70%0.00%91.10%91.10%0.48%-15.91%81.95%81.95%
2015-09-25Quarter-26.39%61.87%0.00%1.78%1.78%0.52%-32.74%38.33%38.33%
2015-12-25Quarter-29.40%-72.56%0.00%-52.12%-52.12%0.14%48.04%-32.19%-32.19%
2016-03-25Quarter-52.36%-62.57%0.00%-17.83%-17.83%0.26%9.54%72.35%72.35%
2016-06-25Quarter-40.07%-73.18%0.00%-76.90%-76.90%0.27%41.51%-61.43%-61.43%
2016-12-25Quarter228.06%-81.42%0.00%-451.19%-451.19%-89.69%84.28%-206.97%-206.97%
2017-03-25Quarter76.05%134.84%0.00%-91.33%-91.33%-89.84%-6.88%-95.09%-95.09%
2017-06-25Quarter-26.74%-3.62%0.00%5.34%5.34%-89.84%-10.03%43.79%43.79%
2017-09-25Quarter10.29%32.75%0.00%-47.43%-47.43%-89.84%-4.83%-52.29%-52.29%
2017-12-25Quarter-85.40%80.05%0.00%-117.81%-117.81%-1.17%-31.14%-222.14%-222.14%
2018-03-25Quarter-55.95%-55.88%0.00%908.81%908.81%0.51%-0.13%2,194.87%2,194.87%
2018-06-25Quarter33.25%-7.96%0.00%-6.07%-6.07%0.38%14.37%-29.45%-29.45%
2018-09-25Quarter19.05%-0.85%0.00%53.87%53.87%0.43%4.94%29.11%29.11%
2018-12-25Quarter68.44%32.44%0.00%-55.33%-55.33%0.37%10.60%-73.46%-73.46%
2019-03-25Quarter35.68%58.32%0.00%-25.38%-25.38%0.34%-4.93%-45.03%-45.03%
2019-06-25Quarter22.93%33.20%0.00%-52.80%-52.80%0.27%-2.31%-61.59%-61.59%


Balance Sheet Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2016-12-25Quarter18,185k305,776k287,591k303,434k48,275k239,316k.063.159
2017-03-25Quarter17,981k295,485k277,504k293,368k36,036k241,468k.065.123
2017-06-25Quarter5,471k282,791k277,320k280,923k51,036k226,284k.020.182
2017-09-25Quarter355k266,739k266,384k265,025k35,477k230,907k.001.134
2017-12-25Quarter-9,338k264,968k274,306k263,412k38,769k235,537k-.034.147
2018-03-25Quarter-19,543k249,303k268,846k247,869k28,589k240,257k-.073.115
2018-06-25Quarter-27,884k305,261k333,145k163,271k33,121k300,024k-.084.203
2018-09-25Quarter-36,303k306,389k342,692k168,090k38,566k304,126k-.106.229
2018-12-25Quarter-40,023k302,147k342,170k167,527k43,200k298,970k-.117.258
2019-03-25Quarter-47,245k290,183k337,428k157,721k38,966k298,462k-.140.247

Balance Sheet Trend

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2017-12-25Quarter-151.35%-13.35%-4.62%-13.19%-19.69%-1.58%-153.97%-7.55%
2018-03-25Quarter-208.69%-15.63%-3.12%-15.51%-20.67%-0.50%-212.31%-6.50%
2018-06-25Quarter-609.67%7.95%20.13%-41.88%-35.10%32.59%-520.00%11.54%
2018-09-25Quarter-10,326.20%14.86%28.65%-36.58%8.71%31.71%-10,700.00%70.90%
2018-12-25Quarter328.60%14.03%24.74%-36.40%11.43%26.93%244.12%75.51%
2019-03-25Quarter141.75%16.40%25.51%-36.37%36.30%24.23%91.78%114.78%


Cash Flow Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##CashFlowHighlights}

Cash Flow Trend

{##CashFlowTrend}


Finance Detail

Income Statement Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Balance Sheet Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Cash Flow Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top




Note